Literature DB >> 28687687

Use of low-dose thrombolytics for treatment of intracardiac thrombus and massive pulmonary embolus after aborted liver transplant leads to recovery of right ventricular function and redo liver transplantation.

Aarya Kafi1, Oren Friedman2, Irene Kim3.   

Abstract

This is a 61-year-old man with end-stage liver disease who experienced cardiac arrest secondary to a massive pulmonary embolus and intracardiac thrombus during cannulation for veno-venous extracorporeal membrane oxygenation (ECMO) in preparation for orthotopic liver transplantation (OLT). Surgery was aborted and the patient was taken back to the intensive care unit in cardiogenic shock on multiple vasopressors. The patient was unresponsive to heparin bolus and too high risk for systemic thrombolytics or embolectomy. He was ultimately treated with 12 mg total of alteplase through his pulmonary artery catheter over 3 hours. He had subsequent resolution of his cardiogenic shock and proceeded with successful liver transplantation 5 days after his initial event without any bleeding complications. Low-dose thrombolytic therapy in the setting of absolute contraindications to thrombolysis allowed for recovery of cardiac function and, ultimately redo OLT in a patient with otherwise little hope of survival. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  adult intensive care; cirrhosis; haematology (drugs and medicines); pulmonary embolism; respiratory system

Mesh:

Substances:

Year:  2017        PMID: 28687687      PMCID: PMC5534737          DOI: 10.1136/bcr-2017-219837

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  17 in total

Review 1.  Massive pulmonary and intracardiac embolism during liver transplantation.

Authors:  Paulo N Martins; Leona Kim-Schluger; Manuel Rodriguez-Davalos; Ann-Britt Martins; Nathalia Krachkova; Marcelo Facciuto; Patricia Sheiner
Journal:  Exp Clin Transplant       Date:  2010-06       Impact factor: 0.945

2.  The efficacy and safety of epsilon-aminocaproic acid treatment in patients with cirrhosis and hyperfibrinolysis.

Authors:  B Gunawan; B Runyon
Journal:  Aliment Pharmacol Ther       Date:  2006-01-01       Impact factor: 8.171

3.  Moderate pulmonary embolism treated with thrombolysis (from the "MOPETT" Trial).

Authors:  Mohsen Sharifi; Curt Bay; Laura Skrocki; Farnoosh Rahimi; Mahshid Mehdipour
Journal:  Am J Cardiol       Date:  2012-10-24       Impact factor: 2.778

4.  The successful use of low-dose recombinant tissue plasminogen activator for treatment of intracardiac/pulmonary thrombosis during liver transplantation.

Authors:  James D Boone; Saadia S Sherwani; Joshua C Herborn; Kinjal M Patel; Andre M De Wolf
Journal:  Anesth Analg       Date:  2010-12-02       Impact factor: 5.108

5.  Intrapulmonary artery infusion of urokinase for treatment of massive pulmonary embolism: a review of 26 patients with and without contraindications to systemic thrombolytic therapy.

Authors:  C J McCotter; K S Chiang; E L Fearrington
Journal:  Clin Cardiol       Date:  1999-10       Impact factor: 2.882

Review 6.  Intraoperative pulmonary embolism and intracardiac thrombosis complicating liver transplantation: a systematic review.

Authors:  N Warnaar; I Q Molenaar; S D Colquhoun; M J H Slooff; S Sherwani; A M de Wolf; R J Porte
Journal:  J Thromb Haemost       Date:  2007-11-14       Impact factor: 5.824

7.  Successful intraoperative use of recombinant tissue plasminogen activator during liver transplantation complicated by massive intracardiac/pulmonary thrombosis.

Authors:  Douglas Jackson; Andrei Botea; Yuriy Gubenko; Ellise Delphin; Henry Bennett
Journal:  Anesth Analg       Date:  2006-03       Impact factor: 5.108

Review 8.  Liver transplantation: past, present and future.

Authors:  Ali Zarrinpar; Ronald W Busuttil
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-06-11       Impact factor: 46.802

9.  Acute massive pulmonary embolism with cardiopulmonary resuscitation: management and results.

Authors:  Igor E Konstantinov; Pankaj Saxena; Miriam D Koniuszko; John Alvarez; Mark A J Newman
Journal:  Tex Heart Inst J       Date:  2007

10.  Efficacy and safety of low dose recombinant tissue-type plasminogen activator for the treatment of acute pulmonary thromboembolism: a randomized, multicenter, controlled trial.

Authors:  Chen Wang; Zhenguo Zhai; Yuanhua Yang; Qi Wu; Zhaozhong Cheng; Lirong Liang; Huaping Dai; Kewu Huang; Weixuan Lu; Zhonghe Zhang; Xiansheng Cheng; Ying H Shen
Journal:  Chest       Date:  2009-09-09       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.